Tiger Global Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,667
Closed -$2.54M 132
2021
Q4
$2.54M Hold
3,667
0.01% 148
2021
Q3
$2.72M Hold
3,667
0.01% 143
2021
Q2
$2.75M Hold
3,667
0.01% 132
2021
Q1
$2.99M Hold
3,667
0.01% 111
2020
Q4
$3.13M Hold
3,667
0.01% 88
2020
Q3
$2.75M Buy
+3,667
New +$3.01M 0.01% 81

Other funds holding OM

Tiger Global Management's OM Position: Q1 2022 in Review

Tiger Global Management sold out of Outset Medical (OM) in Q1 2022, closing a stake of 3,667 shares — an estimated $2.54M sold.

Tiger Global Management first reported a position in OM in Q3 2020 and held it in 6 quarters. The position peaked at $3.13M in Q4 2020. 152 funds tracked by Wall St. Rank hold OM as of Q1 2022.

  • Tiger Global Management reported no remaining Outset Medical position as of Q1 2022 after selling out during the quarter.
  • Tiger Global Management sold 3,667 Outset Medical shares in Q1 2022, an estimated $2.54M.
  • Tiger Global Management first reported a position in Outset Medical in Q3 2020 and held it in 6 quarters.
  • Tiger Global Management's Outset Medical position peaked at $3.13M in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q1 2022.

Based on Tiger Global Management's 13F filing for Q1 2022, filed 16 May 2022.